Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
-
* Corresponding author: Ashley M Croft AshleyCroft@compuserve.com
BMC Public Health 2002, 2:6 doi:10.1186/1471-2458-2-6
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 17 Dec 2001 | |
| Reviewer's Report | R Price | 21 Feb 2002 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 15 Mar 2002 |
| Reviewer's Report | R Price | 25 Mar 2002 | |
| Published | 25 Mar 2002 |